-
-
在线客服
-
-
-
-
我的收藏
-
我的订单
-
快速订购
-
-
-
| 产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
|---|---|---|---|---|
| E892254 | 851895-20-0 | (4-炔基苯基)(吗啉代)甲酮, 98% (4-Ethynylphenyl)(morpholino)methanone, 98% |
C13H13NO2 | |
| 784687 | 88918-72-3 | (4-硝基苯基)甲磺酰胺, 97% (4-Nitrophenyl)methanesulfonamide, 97% |
C7H8N2O4S | |
| B894177 | 159217-89-7 | (4-碘苯基)氨基甲酸叔丁酯, ≥98% tert-Butyl (4-iodophenyl)carbamate, ≥98% |
C11H14INO2 | |
| S893806 | 159991-07-8 | (4aS,7aS)-八氢-1H-吡咯并[3,4-b]吡啶-1-羧酸叔丁酯, ≥95% (4aS,7aS)-tert-Butyl octahydro-1H-pyrrolo[3,4-b]pyridine-1-carboxylate, ≥95% |
C12H22N2O2 | |
| S891771 | 1059630-08-8 | (4aS,9bR)-6-溴-3,4,4a,5-四氢-1H-吡啶并[4,3-b]吲哚-2(9bH)-羧酸乙酯, 97% (4aS,9bR)-Ethyl 6-bromo-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate, 97% |
C14H17BrN2O2 | |
| R686527 | 1335210-35-9 | (4R,12aS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-b)(1,3)恶嗪-9-甲酰胺, 99% (4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, 99% |
C21H21F2N3O5 | |
| R686526 | 1335210-35-9 | (4R,12aS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-b)(1,3)恶嗪-9-甲酰胺, 99.5% (4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, 99.5% |
C21H21F2N3O5 | |
| D851435 | 77877-20-4 | (4R,5S)-3-丙酰基-4-甲基-5-苯基-2-噁唑烷酮, 97% (4R,5S)-4-Methyl-5-phenyl-3-propionyl-2-oxazolidinone, 97% |
C13H15NO3 | |
| M890375 | 96036-02-1 | (4R,5S,6S)-3-[[(3S,5S)-5-[(二甲基氨基)甲酰基-1-[[(4-硝基苄基)氧]羰基]-3-吡咯烷基]硫]-6-[(1R)-1-羟乙基]-4-甲基-7-氧代-1-氮杂双环[3.2.0]庚-2-烯-2-羧酸 4-硝基苄基酯, 98% Meropenem p-nitrobenzyl diester, 98% |
C32H35N5O11S | |
| S682421 | 2452465-41-5 | (4S)-1-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]-2-methoxyethyl]-4-(trifluoromethyl)imidazolidin-2-one, 95% (4S)-1-[(1S)-1-[2-[(S)-amino-(4,4-difluorocyclohexyl)methyl]imidazo[1,2-b]pyridazin-7-yl]-2-methoxyethyl]-4-(trifluoromethyl)imidazolidin-2-one, 95% |
C20H25F5N6O2 | |
| S682426 | 1505514-89-5 | (4S)-4-amino-1-[4-[6-[(R)-1-(3-fluorophenyl)ethoxy]imidazo[1,2-b]pyridazin-3-yl]phenyl]pyrrolidin-2-one, 95% (4S)-4-amino-1-[4-[6-[(R)-1-(3-fluorophenyl)ethoxy]imidazo[1,2-b]pyridazin-3-yl]phenyl]pyrrolidin-2-one, 95% |
C24H22FN5O2 | |
| S824595 | 1260907-17-2 | (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮杂卓-4-乙酰胺, 99% (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 99% |
C22H22ClN5O2 | |
| S794262 | 1260907-17-2 | (4S)-6-(4-氯苯基)-N-乙基-8-甲氧基-1-甲基-4H-[1,2,4]三唑并[4,3-A][1,4]苯并二氮杂卓-4-乙酰胺, 10mM in DMSO (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 10mM in DMSO |
C22H22ClN5O2 | |
| D851436 | 143654-01-7 | (4S,5R)-3-丙酰基-4-甲基-5-苯基-2-噁唑烷酮, ≥97% (4S,5R)-4-Methyl-5-phenyl-3-propionyl-2-oxazolidinone, ≥97% |
C13H15NO3 | |
| B899998 | 329763-32-8 | (5-氨基-2-甲基苯基)氨基甲酸叔丁酯, 97% tert-Butyl (5-amino-2-methylphenyl)carbamate, 97% |
C12H18N2O2 | |
| B892185 | 380629-73-2 | (5-氨基苯并[d]异恶唑-3-基)氨基甲酸叔丁酯, ≥95% tert-Butyl (5-aminobenzo[d]isoxazol-3-yl)carbamate, ≥95% |
C12H15N3O3 | |
| B964854 | 1447607-89-7 | (5-溴-1-甲基-1H-吡唑-3-基)氨基甲酸叔丁酯, 95% tert-Butyl (5-bromo-1-methyl-1H-pyrazol-3-yl)carbamate, 95% |
C9H14BrN3O2 | |
| 784927 | 207922-56-3 | (5-溴吡啶-2-基)氨基甲酸甲酯, 97% Methyl (5-bromopyridin-2-yl)carbamate, 97% |
C7H7BrN2O2 | |
| R956538 | 97859-49-9 | (5R)-5-(羟甲基)-1,3-恶唑烷-2-酮, 97% (R)-5-(Hydroxymethyl)oxazolidin-2-one, 97% |
C4H7NO3 | |
| S929714 | 918542-76-4 | (5S)-3-(3-Acetylphenyl)-N-[(2S,3R)-3-hydroxy-4-[isobutyl[(4-methoxyphenyl)sulfonyl]amino]-1-phenyl-2-butanyl]-2-oxo-1,3-oxazolidine-5-carboxamide1-phenyl-2-butanyl]-2-oxo-1,3-oxazolidine-5-carboxamide, 95% (5S)-3-(3-Acetylphenyl)-N-[(2S,3R)-3-hydroxy-4-[isobutyl[(4-methoxyphenyl)sulfonyl]amino]-1-phenyl-2-butanyl]-2-oxo-1,3-oxazolidine-5-carboxamide1-phenyl-2-butanyl]-2-oxo-1,3-oxazolidine-5-carboxamide, 95% |
C33H39N3O8S |
